In addition, studies have shown that glioma cells produce ADAM10 upon activation, and ADAM10 can induce the development of regulatory B cells (Bregs) by converting latency associated peptide (LAP) into TGF-β in B cells. This evidence concerns the gene TGFB3 and central nervous system cancer.